CD274 and neoplasm: For instance, in hepatocellular carcinoma, the use of the FDA-approved nanoparticle with photothermal abilities could alleviate tumor hypoxia, trigger an antitumor immune response, inhibit tumor metastasis, and induce long-term immunological memory when combined with anti-PD-L1 immunotherapy [146].